We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · August 22, 2020

One-Year Sustained Efficacy of Erenumab in Episodic Migraine



Additional Info

One-Year Sustained Efficacy of Erenumab in Episodic Migraine: Results of the STRIVE Study
Neurology 2020 Aug 04;95(5)e469-e479, PJ Goadsby, U Reuter, Y Hallström, G Broessner, JH Bonner, F Zhang, IK Wright, DE Chou, J Klatt, H Picard, RA Lenz, DD Mikol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading